Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Kips Bay Medical, Inc. (KIPS) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/22/2015 8-K Quarterly results
09/10/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/06/2015 DEF 14A Form DEF 14A - Other definitive proxy statements
08/06/2015 8-K Quarterly results
Docs: "Kips Bay Medical Provides Business Update and Reports Second Quarter 2015 Results MINNEAPOLIS, MN, August 6, 2015 –Kips Bay Medical, Inc. , a medical device company that was focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its second quarter ended June 27, 2015. Feasibility Study and Business Update"
08/06/2015 10-Q Quarterly Report for the period ended June 27, 2015
07/24/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement between Kips Bay Medical, Inc. and Manual Villafaña (Filed herewith)",
"Letter Agreement between Kips Bay Medical, Inc. and Scott Kellen (Filed herewith)"
07/24/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/29/2015 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Plan of Dissolution and Complete Liquidation of Kips Bay Medical, Inc. (Filed herewith)",
"Kips Bay Medical Announces an Orderly Wind Down of Operations with the Termination of"
06/29/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/12/2015 8-K Quarterly results
Docs: "Kips Bay Medical Provides Clinical Trial Update and Reports First Quarter 2015 Results MINNEAPOLIS, MN, May 12, 2015 –Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a clinical trial update and announced financial results for its first quarter ended March 28, 2015. Feasibility Study Update"
05/12/2015 10-Q Quarterly Report for the period ended March 28, 2015
03/24/2015 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Form of Warrant to Purchase Shares of Common Stock of Kips Bay Medical, Inc. (Filed herewith)",
"Securities Purchase Agreement, among Kips Bay Medical, Inc. and the Investors party thereto (Filed herewith)",
"Registration Rights Agreement, among Kips Bay Medical, Inc. and the Investors party thereto (Filed herewith)",
"Employment Agreement, effective as of July 1, 2015, by and between Kips Bay Medical, Inc. and Manuel A. Villafaña (Filed herewith)",
"Kips Bay Medical Announces $3.25 Million Private Placement Bridge Financing"
03/12/2015 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Kips Bay Medical Announces Achievement of Enrollment Goal and Provides Business Update and Fourth Quarter and Full Year 2014 Results"
03/12/2015 10-K Annual Report for the period ended December 31, 2014
01/21/2015 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/05/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Kips Bay Medical Reorganizes Operations and Reduces Staff to Focus on Clinical Study Work and Conserve Capital"
11/06/2014 8-K Quarterly results
Docs: "Kips Bay Medical Provides Feasibility Study Update and Reports Third Quarter 2014 Results MINNEAPOLIS, MN, November 6, 2014 – Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its third quarter ended September 27, 2014. Feasibility Study Update"
11/06/2014 10-Q Quarterly Report for the period ended September 27, 2014
10/23/2014 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
09/04/2014 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
08/12/2014 8-K Quarterly results
Docs: "Kips Bay Medical Provides Feasibility Study Update and Reports Second Quarter 2014 Results MINNEAPOLIS, MN, August 12, 2014 – Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its second quarter ended June 28, 2014. Enrollment Begins at Lenox Hill Hospital in New York"
08/12/2014 10-Q Quarterly Report for the period ended June 28, 2014
05/21/2014 8-K Submission of Matters to a Vote of Security Holders
05/08/2014 8-K Quarterly results
Docs: "Kips Bay Medical Provides Business Update and Reports First Quarter 2014 Results Minneapolis, MN, May 8, 2014 –Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its first quarter ended March 29, 2014. Expanded IDE Approval for U.S. Study Work"
05/08/2014 10-Q Quarterly Report for the period ended March 29, 2014
04/14/2014 DEF 14A Form DEF 14A - Other definitive proxy statements
03/12/2014 8-K Quarterly results
Docs: "Kips Bay Medical Provides Business Update and Reports Fourth Quarter and Full Year 2013 Results Minneapolis, MN, March 12, 2014 –Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its fourth quarter and full year ended December 31, 2013. FDA Update"
03/12/2014 10-K Annual Report for the period ended December 31, 2013
03/07/2014 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
02/05/2014 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Certificate of Amendment to Certificate of Incorporation of Kips Bay Medical, Inc. (filed herewith)"
01/30/2014 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/24/2014 424B2 Form 424B2 - Prospectus [Rule 424(b)(2)]
01/24/2014 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, between Kips Bay Medical, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters named therein (filed herewith)",
"Opinion of Oppenheimer Wolff & Donnelly LLP (filed herewith)",
"Kips Bay Medical, Inc.",
"Kips Bay Medical, Inc."
01/23/2014 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy